User:Mr. Ibrahem/Nilutamide

Nilutamide, sold under the brand names Nilandron and Anandron, is a medication used to treat prostate cancer. It has also been used as a component of feminizing hormone therapy for transgender women. It is taken by mouth

Common side effects may include hot flushes, poor ability to see in darkness, nausea, constipation, trouble sleeping, and breat enlargement. Other side effects may include sexual dysfunction, osteoporosis, alcohol intolerance Rarely, it can cause pneumonitis and liver damage. These unfavorable side effects have limited it use.

Nilutamide is a nonsteroidal antiandrogen (NSAA) which acts as a selective antagonist of the androgen receptor (AR), preventing the effects of androgens. As prostate cancer rely on these hormones for growth and survival, it can slow the progression of the disease.

Nilutamide was discovered in 1977 and was approved for medical use in 1987. It was approved in the United States in 1996. It is on the World Health Organization's List of Essential Medicines as an alternative to bicalutamide. It is available as a generic medication. In the United States 30 tablets of 150 mg costs about 1,600 USD as of 2021.